GeneDx To Present New Results At International Consortium On Newborn Sequencing For Its Genomic Newborn Screening

GeneDx (Nasdaq: WGS) will present new findings at the International Consortium on Newborn Sequencing (ICoNS) on October 7-8 in Boston. The presentation will highlight advancements in making genomic newborn screening (gNBS) more scalable and accessible in proactive healthcare.